FRIDAY, Nov. 25 (HealthDay News) — Patients hospitalized for autoimmune disorders, like rheumatoid arthritis or Crohn’s disease, may be at greater risk for a life-threatening pulmonary embolism, a clot in a main artery of the lung, a new study finds.
Reporting online Nov. 25 in The Lancet, researchers warned that steps should be taken to prevent this condition among patients admitted to the hospital for autoimmune diseases.
By Mary Brophy Marcus
HealthDay Reporter
THURSDAY, Nov. 10 (HealthDay News) — A new study by Japanese researchers gives hope that one day people with pituitary gland failure may be able to receive transplants of stem-cell generated tissue to help restore normal function of the gland.
Without the pea-size pituitary gland, which sits at the base of the brain, the body wouldn’t survive. It controls the production and function of many hormones, including ones linked to growth, fertility, stress and temperature regulation.
TUESDAY, Oct. 11 (HealthDay News) –
With private companies marketing genetic tests — which measure people’s risk for certain diseases — directly to patients, concerns have risen about people’s ability to handle that information on their own.
Although a new study found the mail-in kits, which cost up to $2,500, do not result in excessive worry about illness, the researchers argued that being at very low risk for disease may prompt some users to make worse decisions about their heath.
WEDNESDAY, July 13 (HealthDay News) — For patients taking the heart rhythm drug amiodarone (Cordarone), generic versions of the drug do not cause more incidents of thyroid dysfunction than the brand-name medication, researchers report.
When it comes to thyroid disease, there is no difference between the two drugs, according to the report released online July 11 in CMAJ (Canadian Medical Association Journal).
Read More
TUESDAY, June 14 (HealthDay News) — Patients with early-stage chronic kidney disease are more likely to die if they have elevated levels of a certain hormone, a new study says.
Endocrine hormone fibroblast growth factor 23 (FGF-23) regulates phosphorus metabolism. It was known that levels of FGF-23 increase as kidney function declines and that high levels of the hormone are associated with increased risk of death in patients with kidney failure. But little was known about how elevated levels of FGF-23 affect outcomes of patients with early-stage chronic kidney disease.
THURSDAY, Jan. 21 (HealthDay News) — Chemicals found in carpeting, non-stick cookware and fabrics are linked to an increase in thyroid disease, new research suggests.
British researchers analyzed blood serum levels of two types of perfluorinated chemicals in nearly 4,000 U.S. adult men and women, using data from U.S. Centers for Disease Control and Prevention’s National Health and Nutrition Examination Survey (NHANES). Read More
FRIDAY, Nov. 6 (HealthDay News) — New research suggests that living near a volcano puts people at higher risk of getting a type of thyroid cancer.
It’s not clear how volcanoes might be related to cancer, but researchers suspect that the toxic compounds they produce could play a role.
Researchers are also unsure of why thyroid cancer rates are rising around the world. It’s possibly because of better detection, but the environment is a potential factor as well, they believe. Read More
TUESDAY, July 14 (HealthDay News) — Intensified screening doesn’t entirely explain the jump in thyroid cancers noted in the United States since 1980, and scientists now believe that other as-yet-unknown factors are to blame.
A new study finds that thyroid tumors of all sizes are being picked up, not just the smaller ones that more aggressive screening would be expected to detect. Read More
WEDNESDAY, Oct. 15 (HealthDay News) — People with a thyroid disorder run an increased risk of developing the eye disease glaucoma, a new study suggests.
In fact, those with glaucoma are 38 percent more likely to have had a thyroid condition at some point in their life, said the study authors, from the University of Alabama at Birmingham. Glaucoma is the leading cause of irreversible blindness worldwide.
“Studies like this are very useful in understanding what causes this disease,” said lead researcher Gerald McGwin, vice chairman of the Department of Ophthalmology at the university’s School of Medicine. Read More
| Text Size: |  |
|
